Answers are grounded in this paper and cite their sources.
The use of alternative viral envelope proteins to pseudotype oncoretroviral vectors has contributed substantially to recent improvements in retroviral gene transfer to hematopoietic stem cells. The envelope protein of endogenous feline leukemia virus (RD114) has emerged as a particularly attractive candidate in this context. Initial studies of RD114-pseudotype vectors produced by FLYRD18 packaging cells have shown promise, but it has also been demonstrated that FLYRD18 produces soluble factors that interfere with stem cell maintenance.
No takes yet. Share an insight, caveat, or question.
Neff et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: